Chlamydia pneumoniae and cytomegalovirus infection and cardiovascular remodeling in hypertensives

被引:0
作者
Jastrzebski, Marek [1 ]
Czarnecka, Danuta [1 ]
Rajzer, Marek [1 ]
Marcinkowski, Marcin [1 ]
Kawecka-Jaszcz, Kalina [1 ]
机构
[1] Uniwersytet Jagiellonski, Klin Kardiol 1, Coll Med, Ul Kopernika 17, PL-31501 Krakow, Poland
来源
ARTERIAL HYPERTENSION | 2005年 / 9卷 / 04期
关键词
Chlamydia pneumoniae; Cytomegalovirus; arterial hypertension; intima-media thickness; pulse wave velocity; diastolic function;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background We investigated infuence of Chlamydia pneumoniae (Ch.p.) and Cytomegalovirus (CMV) infection on cardiovascular remodeling in essential hypertension. Material and methods 112 hypertensives were included in the study (age: 55,7 +/- 12 y, known duration of hypertension 12,7 +/- 8 y). Antibodies against Ch.p, CMV, human HSP60 and ICAM-1, CRP and TNF-alpha levels were assessed. To assess cardiovascular remodeling following investigations were performed: carotid intima-media thickness (IMT), carotid-femoral pulse wave velocity (PWV), left ventricular mass index (LVMI), diastolic function (IVRT - isovolumetric relaxation time, E/A - mitral inflow waves ratio, EDT - E wave deceleration time, AR - reversal flow in pulmonary veins during atrial contraction, S/D pulmonary inflow waves ratio). Results 66 patients (59%) were seropositive for Ch.p., and 86 (77%) for CMV. Ch.p (+) group had higher IMT values (0,84 vs. 0,93 mm, p = 0,001), lower E/A (0,94 vs. 1/03, p = 0,03) and higher CRP level (1,8 vs. 1,37 mg/l, p = = 0,07). After adjusting for age these differences ceased to be significant. CMV (+) group had longer IVRT (96,3 vs. 88,8 ms, p = 0,06), higher PWV (10,5 vs. 9,3 m/s, p = = 0,006), lower E/A (0,93 vs. 1,2, p = 0,0001), higher AR (34,9 vs. 30,7 cm/s, p = 0,007), higher CRP (1,8 vs. 1,17 mg, p = 0,037) and ICAM-1 (269,9 vs. 237,2, p = 0,028) levels. After adjusting for age, BMI and cholesterol only differences in E/A, AR and CRP remained significant. There were several significant weak correlations in univariate and multivariate analysis between antibodies levels and indices of remodeling. Conclusions CMV and Chlamydia pneumoniae infection influences in a small degree both cardiovascular remodeling indices and inflammatory markers in essential hypertensives.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 42 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]   Chlamydia pneumoniae seropositivity and cardiovascular risk factors:: The InCHIANTI study [J].
Blanc, P ;
Corsi, AM ;
Gabbuti, A ;
Peduzzi, C ;
Meacci, F ;
Olivieri, F ;
Lauretani, F ;
Francesco, M ;
Ferrucci, L .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (10) :1626-1631
[3]   Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Bickel, C ;
Espinola-Klein, C ;
Rippin, G ;
Hafner, G ;
Ossendorf, M ;
Steinhagen, K ;
Meyer, J .
CIRCULATION, 2001, 103 (24) :2915-2921
[4]  
Chiu B, 1997, CIRCULATION, V96, P2144
[5]   Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease [J].
Ciervo, A ;
Visca, P ;
Petrucca, A ;
Biasucci, LM ;
Maseri, A ;
Cassone, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (01) :66-74
[6]   Chlamydia pneumoniae antibodies in severe essential hypertension [J].
Cook, PJ ;
Lip, GYH ;
Davies, P ;
Beevers, DG ;
Wise, R ;
Honeybourne, D .
HYPERTENSION, 1998, 31 (02) :589-594
[7]   Chlamydia pneumoniae IgG titres and coronary heart disease:: prospective study and meta-analysis [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Wong, YK ;
Bernardes-Silva, M ;
Ward, M .
BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :208-212
[8]   Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis [J].
Dechend, R ;
Maass, M ;
Gieffers, J ;
Dietz, R ;
Scheidereit, C ;
Leutz, A ;
Gulba, DC .
CIRCULATION, 1999, 100 (13) :1369-1373
[9]  
Dyszkiewicz W, 2002, Pol Merkur Lekarski, V12, P11
[10]   Association of C-reactive protein with markers of prevalent atherosclerotic disease [J].
Folsom, AR ;
Pankow, JS ;
Tracy, RP ;
Arnett, DK ;
Peacock, JM ;
Hong, YL ;
Djoussé, L ;
Eckfeldt, JH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (02) :112-117